we have compared two dose levels of clozic , a novel agent with potential anti-rheumatoid activity , to d-penicillamine and aspirin in an observer blind randomised parallel group study of 56 patients with active rheumatoid arthritis .
C0030817
penicillamine
C0003873
rheumatoid arthritis